Big Pharma's going to court | There's hope for the UK yet |

Hi Finimizer, here's what you need to know for August 15th in 3:15 minutes.

💻 Not all tech stocks are created equal: while some are suffering at the hands of inflation, others are thriving from it. So join The Motley Fool’s Asit Sharma for How To Spot The Best Tech Stocks on Tuesday, and discover the three tech stocks that are still worth buying. Get your free ticket

Today's big stories

  1. Investors ditched shares of major pharmaceutical companies last week ahead of a major lawsuit
  2. Our analyst has laid out how to fix the one big mistake most investors make at times like this – Read Now
  3. The UK economy shrank slightly less than expected in the second quarter

Big Pharma Is Headed For A Big Lawsuit

Big Pharma Is Headed For A Big Lawsuit

What’s Going On Here?

Shares of major pharmaceutical firms GlaxoSmithKline (GSK), Haleon, and Sanofi tumbled last week as a potentially cancer-causing drug goes to court.

What Does This Mean?

Heartburn drug Zantac was pulled from the market in 2020 when it was found to contain a cancer-causing substance, and drugmakers GSK and Sanofi have been braced for a lawsuit ever since. But if investors were shocked that Big Pharma could put profit above health, they certainly didn’t show it – until now. Legal proceedings are kicking off next week, and investors suddenly seem a lot more nervous about holding stocks that could be affected. There could be a few worth worrying about too, since Sanofi is just one of many drugmakers with rights to the drug, and there are a handful of distributors involved as well. But GSK could have the most to lose: the powerhouse first brought Zantac to the market, and its spin-off Haleon might be tarred with the same brush. Investors just ditched them all: shares of GSK, Haleon, and Sanofi fell about 10% last week.

Why Should I Care?

For markets: Bayer’s remorse.
Investors value a company based on the cash it’s expected to make in the future, so anything – including potentially billion-dollar lawsuits – that threatens those cash flows will reduce what an investor’s willing to pay for the shares today. After all, they’ve seen profit-wrecking pharma payouts before: Bayer bought agricultural biotechnology firm Monsanto for $63 billion in 2018, and ended up paying $12 billion only a couple years later to settle lawsuits around Monsanto’s weed-killer Roundup.

For you personally: Not-so-defensive stock.
This isn’t great timing: investors tend to hold healthcare stocks during recessionary times like these because they make products people need no matter what. Still, some investors will fare better than others: those who own a basket of healthcare stocks via an exchange-traded fund – rather than individual ones – are better protected against selloffs that affect a few specific companies.

Copy to share story:

🙋 Ask a question

Analyst Take

How To Build A Robust Portfolio

How To Build A Robust Portfolio
Photo of Stéphane Renevier

Stéphane Renevier, Analyst

There’s one big mistake a lot of investors make.

They spend plenty of time thinking about what to include in their portfolio, and very little thinking about how much money to allocate to each position.

It’s a costly and avoidable error: you could create a much stronger portfolio just by having the right mix of assets.

And as luck would have it, there are three simple steps that can help you achieve just that.

That’s today’s Insight: how to build a more robust portfolio.

Read or listen to the Insight here


Crypto can be loyal

You might not have heard of loyalty tokens in crypto, and that’s a real shame.

See, they have a lot of potential: you can cash them out for real fiat, meaning they’re a closer equivalent to cold, hard cash. Thing is, few projects have zoned in on loyalty tokens so far.

Now you can unlock their full potential by collecting loyalty rewards with Verse in the same way that you rack up frequent flier points, and you can convert them into cash at any point.

Verse is set to help power the mighty ecosystem that’s already used by millions around the globe, and you can find out more about the utility token in the Verse whitepaper.

Limited Verse tokens will go on sale soon, so best get pre-approved today.

Discover Verse

The Verse token sale is not available in the U.S. and other restricted jurisdictions.

The UK Is Flirting With Recession

The UK Is Flirting With Recession

What’s Going On Here?

Data out on Friday showed the UK economy shrank less than expected in the second quarter.

What Does This Mean?

The UK economy shrank 0.1% last quarter compared to the one before, but it could’ve been worse: economists were expecting twice that, at a time when every increment matters. That marks the first contraction in the economy since the height of the pandemic, and it was down to a domino effect of factors. High inflation has been stoking the cost-of-living crisis, which has left Brits with less disposable income to spend out and about. That, in turn, led to a drop in household consumption (partly reflected in weak retail sales), and a drop in manufacturing. It’s also worth bearing in mind that there was one day less of business, with Brits given a day off to celebrate the Queen’s Platinum Jubilee. So when you put it all together, less shrinkage than expected was actually something of a win.

Why Should I Care?

For markets: You can relax. 
You need two quarters of contraction in a row for an economy to officially be in a recession, and Bloomberg Economics doesn’t think that’ll happen just yet. After all, Brits don’t have a royal day off this time around, which means the economy – measured relative to the quarter before – has an extra day to boost its numbers. And even if there is a downturn, it’s not the end of the world: the US is technically in a recession, but investors seem to have shrugged it off.

The bigger picture: You can stop relaxing now. 
The UK might avoid a recession this year, but the Bank of England (BoE) thinks it’s bound to arrive in 2023 (tweet this). The central bank puts that down to – what else? – inflation, which it thinks will peak at around 13% in October on the back of rising energy prices. Then again, the UK energy regulator’s latest data suggests the BoE is still underestimating energy costs, which arguably means it’s still underestimating inflation too…

Copy to share story:

🙋 Ask a question

💬 Quote of the day

“Don’t take life too seriously. You will never get out of it alive.”

– Elbert Hubbard (an American writer, artist, and philosopher)
Tweet this

📝 [Insert your company’s name here]

Your company’s name would look pretty good in this space, huh?

We’re sure our one million engaged investors would think so too.

If you want to spread the word about your business, chat to us about our daily newsletter slots. They’re the perfect opportunity for you to speak directly with the Finimize community.

Sound good? Get in touch.

Work With Us

🌍 Finimize Live

🎉 Coming Up This Week…

All events in UK time.

🤑 How To Protect Your Crypto Portfolio During A Recession: 5pm, August 15th
💰 The Secret To Making Money During High Inflation: 1pm, August 16th
💻 How To Spot The Best Tech Stocks: 6pm, August 16th
🤯 Inflation Strategies For Savvy Investors: 12pm, August 18th
☃️ How To Stay Warm In A Crypto Winter: 5pm, August 18th

🥳 And After That…

🏈 Crypto And The Sports Community: 5pm, August 23rd
👑 How To Invest In Gold On The Blockchain: 5pm, August 25th
😎 How To Spot The Next Ethereum Killer: 1pm, August 30th
🧬 How To Profit From The Genomics Revolution: 5pm, August 30th
🎉 How To Build Wealth In Your 20s: 5pm, September 1st

🎯 On Our Radar

  1. Nokia’s a musical genius. No one can top those ringtones.
  2. Become a better conversationalist. You’ll never need to make small talk again.
  3. “The Sopranos” lives on. We’re still dressing like Tony.
  4. Meditation in real life can be life-changing. Just imagine meditation in virtual reality.
  5. Renting is getting worse. Londoners are now sleeping in kitchens.
❤️ Share with a friendYour Referrals: 0

Thanks for reading. If you liked today's brief, we'd love for you to share it with a friend.

Share your unique link:

You stay classy, Finimizer 😉

We’d love to hear your thoughts. Give feedback

Want to advertise with us too? Get in touch

Image Credits:

Image credits: Wikimedia Commons | eamesBot - Shutterstock


View in browser

Unsubscribe from all Finimize Emails


Crafted by Finimize Ltd. | Bow Bells House, Bread Street, London, EC4M 9HH

All content provided by Finimize Ltd. is for informational and educational purposes only and is not meant to represent trade or investment recommendations. You signed up to this mailing list at or through one of our partners. © Finimize 2021

View Online